Insider Transactions in Q3 2021 at Paratek Pharmaceuticals, Inc. (PRTK)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2021
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
10,975
-2.14%
|
$54,875
$5.12 P/Share
|
|
Aug 17
2021
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
8,766
-3.02%
|
$43,830
$5.12 P/Share
|
|
Aug 17
2021
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
32,030
-3.36%
|
$160,150
$5.12 P/Share
|
|
Aug 17
2021
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
9,692
-2.55%
|
$48,460
$5.12 P/Share
|
|
Aug 17
2021
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
33,931
-3.28%
|
$169,655
$5.12 P/Share
|
|
Aug 16
2021
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+6.82%
|
-
|
|
Aug 16
2021
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
21,250
+6.82%
|
-
|
|
Aug 16
2021
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+7.29%
|
-
|
|
Aug 16
2021
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
23,125
+5.73%
|
-
|
|
Aug 16
2021
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+6.76%
|
-
|